Teasing out the best molecular marker in the AKT/MTOR pathway in HNSCC patients

OBJECTIVES: No reliable molecular biomarker is currently available for clinical application in the management of head and neck cancer patients. The AKT/MTOR pathway is activated in 90-100% of HNSCC and could be promising biomarkers closely linked to cancer incidence. METHODS: Oral mucosa from non-ca...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Clark, Cheryl, Shah, Shivang, Herman-Ferdinandez, Lilantha, Ekshyyan, Oleksandr, Abreo, Fleurette, Rong, Xiaohua, McLarty, Jerry, Lourie, Aubrey, Milligan, Edward J., Nathan, Cherie-Ann O.
Format: Artigo
Jezik:Inglês
Izdano: 2010
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2997737/
https://ncbi.nlm.nih.gov/pubmed/20513033
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/lary.20917
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items